Pulmonary venous circulating tumour cell dissemination before tumour resection and disease relapse

Approximately 50% of early-stage non-small cell lung cancer (NSCLC) patients that undergo surgery with curative intent will relapse within 5 years(1,2). Detection of circulating tumour cells (CTCs) at the time of surgery may represent a tool to identify patients at higher risk of recurrence where mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Med
Autors principals: Chemi, Francesca, Rothwell, Dominic G, McGranahan, Nicholas, Gulati, Sakshi, Abbosh, Chris, Pearce, Simon P, Zhou, Cong, Wilson, Gareth, Jamal-Hanjani, Mariam, Birkbak, Nicolai, Pierce, Jackie, Kim, Chang Sik, Ferdous, Saba, Burt, Deborah, Slane-Tan, Daniel, Gomes, Fabio, Moore, David, Shah, Rajesh, Al Bakir, Maise, Hiley, Crispin, Veeriah, Selvaraju, Summers, Yvonne, Crosbie, Philip, Ward, Sophia, Mesquita, Barbara, Dynowski, Marek, Biswas, Dhruva, Tugwood, Jonathan, Blackhall, Fiona, Miller, Crispin, Hackshaw, Allan, Brady, Ged, Swanton, Charles, Dive, Caroline
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986897/
https://ncbi.nlm.nih.gov/pubmed/31591595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-019-0593-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars